Phytoseptil capsules nez-gorge-bronches
Food supplement declared in France, declaration No 2023-3-271
Phytoseptil capsules nez-gorge-bronches, from LABORATOIRES NOVODEX PHARMA, is a food supplement declared in France. Status: withdrawn from the market on 31 December 2025. Main ingredients: Eucalyptus globulus 120 mg per day, Mentha x 120 mg per day, Pinus sylvestris 90 mg per day, Thymus serpyllum 60 mg per day, Vitamin D. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRES NOVODEX PHARMA
- Status
- Withdrawn from the market on 31 December 2025
- Form
- Capsule
- Daily dose
- 3 capsules
- Directions for use
- 3 capsules par jour avec un verre d’eau
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Kidney stones, Children (under 12), Pregnant women, Kidney failure, Infants (under 1 year), Taking anticoagulants, Taking medication, Prolonged use, Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Respiratory tract
Declaration 309349, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Eucalyptus globulus Labill. | Essence (feuille) | Distillation | 120 mg |
| Mentha x piperita L. | Essence (feuille) | Distillation | 120 mg |
| Pinus sylvestris L. | Essence (parties aériennes) | Distillation | 90 mg |
| Thymus serpyllum L. | Essence (parties aériennes) | Distillation | 60 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| cholecalciferol | Vitamin D | 100 µg (4,000 IU) | 5 µg (200 IU) |
Additives
E422, E407, E339
Other ingredients
huile de colza, amidon de maïs modifié
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Ne convient pas aux enfants et adolescents encore en croissance, aux femmes enceintes ou en période d'allaitement. Demandez conseil à un professionnel en cas de troubles gastro-oesophagiens, de traitement antiépileptique ou d'antécédent de convulsion, d'obstruction des voies biliaires (calculs) ou de troubles hépato-pancréatique ou d'insuffisance rénale sévère. Déconseillé en cas de prise simultanée de médicament, notamment d'anticoagulant. Ne pas utiliser avant un acte chirurgical et toutes situations à risques hémorragiques. Déconseillé en cas d'antécédent de pathologies neurologiques. Pas d'utilisation prolongée, maximum 10 jours de prise. À consommer de préférence avant la date indiquée sur l'étui. Ne pas dépasser la dose journalière recommandée. À conserver au frais, au sec et à l'abri de la lumière.
Regulatory points
- Information
Withdrawn from the market on 31 December 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Mentha x piperita L.
Read the warning, when it applies and the studies cited
PEPPERMINT - MENTHA X PIPERITA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Condition of application: Essential oil.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Condition of application: Essential oil.
When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (2)
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Phytoseptil capsules nez-gorge-bronches: composition and regulation”, https://compoatlas.com/en/supplements/products/309349-phytoseptil-capsules-nez-gorge-bronches, updated 15 November 2026.